Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients: Implications for Assessing Personal Versus Familial Financial Toxicity via the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy (COST-FACIT) Survey Instrument.

Saved in:
Bibliographic Details
Title: Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients: Implications for Assessing Personal Versus Familial Financial Toxicity via the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy (COST-FACIT) Survey Instrument.
Authors: Kasliwal N; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH., Stephens MJ; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH.; Medical College of Georgia, Augusta, GA., Burnette UJ; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH., Onyewadume L; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH.; Department of Radiation Oncology, Duke University School of Medicine, Durham, NC., McClelland S 3rd; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH.; Departments of Radiation Oncology and Neurological Surgery, University of Oklahoma College of Medicine, Oklahoma City, OK.
Source: American journal of clinical oncology [Am J Clin Oncol] 2025 Jul 01; Vol. 48 (7), pp. 342-344. Date of Electronic Publication: 2025 Mar 26.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-453X
DOI:10.1097/COC.0000000000001190